N-Acetylcysteine protects the peritoneum from the injury induced by hypertonic dialysis solution

被引:4
作者
Bui, Deborah S. S. [1 ]
Seguro, Antonio C. [1 ]
Shimitzu, Maria H. [1 ]
Schliemann, Igor [2 ]
Martini, Dino [2 ]
Romao, Joao E., Jr. [1 ]
Pecoits Filho, Roberto F. [3 ]
Abensur, Hugo [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
[2] Santa Casa de Misericordia Hosp Sao Paulo, Sao Paulo, Brazil
[3] Pontificia Univ Catolica Parana, Ctr Hlth & Biol Sci, Curitiba, Parana, Brazil
关键词
Acetylcysteine; Animal models; Oxidative stress; Peritoneal dialysis; OXIDATIVE STRESS; ADVANCED GLYCATION; RAT; PERMEABILITY; INFUSION; FLUID; MODEL;
D O I
10.5301/JN.2011.8404
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Oxidative stress has been implicated in the development of peritoneal damage. The aim of this study was to evaluate the effects of N-acetylcysteine (NAC) in a rat peritoneal infusion model. Methods: Eighteen male Wistar rats were divided in 3 groups: (i) control group; (ii) HDS group, receiving peritoneal dialysis solution (PDS); and (iii) HDS+NAC group, receiving PDS and oral NAC. Six weeks later they were evaluated for dialysate to plasma urea ratio (D/P), ratio of glucose concentration in peritoneal fluid (G1/G0), thiobarbituric acid reactive substances in plasma and urine and histology of peritoneal membrane. Results: The HDS+NAC group presented a lower increase in solute transport (D/P 0.51 +/- 0.1, and G1/GO 0.35 +/- 0.06) in comparison with the HDS group (D/P 0.67 +/- 0.1; p=0.03, and G1/G0 0.27 +/- 0.07; p=0.01). The HDS+NAC group showed lower thiobarbituric acid reactive substance concentrations compared with the HDS group. In the treated group, the peritoneal membrane presented lower thickness. Conclusions: Functional and histological peritoneal changes were significantly reduced by the treatment with NAC.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 21 条
[11]   EFFECT OF ORAL N-ACETYLCYSTEINE TREATMENT ON PLASMA INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PERITONEAL DIALYSIS PATIENTS: A PLACEBO-CONTROLLED STUDY [J].
Nascimento, Marcelo M. ;
Suliman, Mohamed E. ;
Silva, Margarete ;
Chinaglia, Tiago ;
Marchioro, Josiane ;
Hayashi, Shirley Y. ;
Riella, Miguel C. ;
Lindholm, Bengt ;
Anderstam, Bjorn .
PERITONEAL DIALYSIS INTERNATIONAL, 2010, 30 (03) :336-342
[12]   Oxidative stress during peritoneal dialysis: Implications in functional and structural changes in the membrane [J].
Noh, H. ;
Kim, J. S. ;
Han, K-H ;
Lee, G. T. ;
Song, J. S. ;
Chung, S. H. ;
Jeon, J. S. ;
Ha, H. ;
Lee, H. B. .
KIDNEY INTERNATIONAL, 2006, 69 (11) :2022-2028
[13]  
Schwenger VV, 2005, J AM SOC NEPHROL, V30, P117
[14]  
Shimizu MHM, 2005, KIDNEY INT, V68, P2208, DOI 10.1111/j.1523-1755.2005.00677.x
[15]  
Smit W, 2004, PERITON DIALYSIS INT, V24, P506
[16]   Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine [J].
Tepel, M ;
van der Giet, M ;
Schwarzfeld, C ;
Laufer, U ;
Liermann, D ;
Zidek, W .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (03) :180-184
[17]  
Waart DR, 2001, PERITON DIALYSIS INT, V21, P269
[18]   Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients [J].
Wang, T ;
Heimburger, O ;
Waniewski, J ;
Bergstrom, J ;
Lindholm, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) :1242-1249
[19]  
Zeltzer E, 2000, PERITON DIALYSIS INT, V20, P656
[20]  
Zweers MM, 2001, NEPHROL DIAL TRANSPL, V16, P651